ADENOCAP

Welcome to the Brand page for “ADENOCAP”, which is offered here for Pharmaceutical preparations for the treatment of covid-19 and human adenovirus infections for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of covid-19 and human adenovirus infections; diagnostic kits for covid-19 and human adenovirus infections for medical or clinical use; vaccines for covid-19 and human adenovirus infections;.

Its status is currently believed to be active. Its class is unavailable. “ADENOCAP” is believed to be currently owned by “NANTCELL, INC.”